A detailed history of Ci Investments Inc. transactions in Organon & Co. stock. As of the latest transaction made, Ci Investments Inc. holds 923 shares of OGN stock, worth $14,103. This represents 0.0% of its overall portfolio holdings.

Number of Shares
923
Previous 472 95.55%
Holding current value
$14,103
Previous $10,000 80.0%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.65 - $23.03 $8,411 - $10,386
451 Added 95.55%
923 $18,000
Q2 2024

Aug 12, 2024

SELL
$17.45 - $21.96 $645 - $812
-37 Reduced 7.27%
472 $10,000
Q1 2024

May 13, 2024

SELL
$13.78 - $18.8 $47,224 - $64,427
-3,427 Reduced 87.07%
509 $10,000
Q4 2023

Feb 12, 2024

SELL
$10.95 - $17.32 $50,578 - $80,001
-4,619 Reduced 53.99%
3,936 $57,000
Q3 2023

Nov 13, 2023

SELL
$16.59 - $23.77 $12,177 - $17,447
-734 Reduced 7.9%
8,555 $149,000
Q2 2023

Aug 11, 2023

BUY
$19.27 - $24.63 $55,015 - $70,318
2,855 Added 44.37%
9,289 $193,000
Q1 2023

May 12, 2023

BUY
$21.42 - $32.08 $47,038 - $70,447
2,196 Added 51.82%
6,434 $151,000
Q4 2022

Feb 10, 2023

SELL
$23.31 - $28.61 $14,755 - $18,110
-633 Reduced 13.0%
4,238 $118,000
Q3 2022

Nov 14, 2022

SELL
$23.4 - $34.25 $5,475 - $8,014
-234 Reduced 4.58%
4,871 $114,000
Q2 2022

Aug 12, 2022

SELL
$31.66 - $38.9 $145,002 - $178,162
-4,580 Reduced 47.29%
5,105 $172,000
Q1 2022

May 12, 2022

SELL
$30.45 - $39.36 $32,825 - $42,430
-1,078 Reduced 10.02%
9,685 $338,000
Q4 2021

Feb 11, 2022

BUY
$28.67 - $37.13 $276,808 - $358,490
9,655 Added 871.39%
10,763 $328,000
Q3 2021

Nov 12, 2021

BUY
$28.63 - $35.64 $31,722 - $39,489
1,108 New
1,108 $36,000

Others Institutions Holding OGN

About Organon & Co.


  • Ticker OGN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 254,330,000
  • Market Cap $3.89B
  • Description
  • Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...
More about OGN
Track This Portfolio

Track Ci Investments Inc. Portfolio

Follow Ci Investments Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ci Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Ci Investments Inc. with notifications on news.